Results 251 to 260 of about 11,507,104 (364)
Lipid-Lowering Drugs and Pulmonary Vascular Disease: A Mendelian Randomization Study. [PDF]
Yuan X, Hong P, Zhou J.
europepmc +1 more source
Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee +4 more
wiley +1 more source
Matrix Metalloproteinases and Their Inhibitors in the Pathogenesis of Epithelial Differentiation, Vascular Disease, Endometriosis, and Ocular Fibrotic Pterygium. [PDF]
Park JY +5 more
europepmc +1 more source
This research introduces a cold plasma‐based platform for treating breast cancer bone metastases. Using a novel bioprinted 3D tumor‐stroma model, it highlights the selective antitumor effects of plasma‐generated reactive species. The platform aims to advance non‐invasive therapeutic strategies, offering potential clinical applications in controlling ...
Laura M. Bouret +4 more
wiley +1 more source
Hyperhomocysteinemia: an independent risk factor for vascular disease.
R. Clarke +6 more
semanticscholar +1 more source
Evaluating the quantity and spatial density of macrophage-like cells in patients with retinal vascular disease and healthy subjects via non-invasive retinal imaging. [PDF]
Ghaseminejad F +9 more
europepmc +1 more source
Tannic acid‐selenocystamine (TA‐SeCA) nanocoating enables stable, sustained catalytic nitric oxide (NO) release on catheter surfaces. This one‐step phenol‐amine coating improves catheter functionality by enhancing endogenous NO production, supporting vascular function, and reducing inflammation.
Qingqing Fan +7 more
wiley +1 more source
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Melanie D. Sweeney +68 more
semanticscholar +1 more source

